Impact of Lipidomics Conference Series
脂质组学会议系列的影响
基本信息
- 批准号:8993903
- 负责人:
- 金额:$ 1.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-15 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressApplications GrantsAreaBiochemistryBiological ProcessBiologyBooksBusinessesCellsCellular biologyClassificationCollaborationsCommunitiesCountryDataDatabasesDevelopmentDisadvantagedDisciplineDiseaseEducational workshopEvaluationExposure toFeesFundingGenomicsGoalsGrantGrowthHealthInstitutionInterventionLipidsLocationMeasuresMethodologyMethodsModelingMolecularNational Institute of General Medical SciencesOutcomeParticipantPharmacologyPlayProteomicsPublicationsResearchResearch MethodologyResource SharingResourcesRoleRunningScienceScientific Advances and AccomplishmentsScientistSeriesStructureStudentsSurveysSystemSystems BiologyTimeTissuesTravelUnderrepresented GroupsUnited States National Institutes of HealthWomanWorkabstractingbasedata sharingeffective therapyexperiencelipid metabolismmass spectrometermeetingsmultidisciplinarynovel strategiesoutreachplanetary Atmospherepostersprogramsresponsesuccesssymposiumtoolweb site
项目摘要
DESCRIPTION (provided by applicant): This proposal aims to continue and expand on the very successful LIPID MAPS Annual Meetings by holding a series of annual "Impact of Lipidomics" scientific conferences in 2014, 2015, and 2016 focused on lipidomics and its biomedical applications. Following on numerous initiatives in genomics and proteomics, the NIGMS sponsored LIPID MAPS was the world's first major lipidomics initiative. It pursued a mandate to proactively share its data, methods, tools and other resources with the entire research community since its inception in 2003. One of its most successful outreach mechanisms has been its public Annual Meetings - the fourth held this past May, 2012. The field has seen considerable growth since the word "lipidomics" was first used in scientific publications and grant applications in 2002. The total number of NIH-funded projects passed 130 in 2012, and the total number of lipidomic(s) publications has grown to over 700. The LIPID MAPS initiative which ends in July 2013, and cannot be renewed, has already generated several hundred publications. The science of lipidomics uses a systems biology approach and sophisticated mass spectrometers to identify and quantify the lipid species in cells and tissues and to quantify the changes in these species in response to perturbations or disease. Its ultimate goal is to better understand the fundamental biological processes of lipid metabolism at the molecular level, the active role lipids play in the wide range of lipid-based diseases and to facilitate development of more effective pharmacological intervention and treatments. The overall goal of the series is to motivate and facilitate advances in the lipidomics field while extending the applications of lipidomics to new areas of cell biology, biochemistry, pharmacology, and biomedicine. The main objectives are to: 1) disseminate new findings, methodologies, and tools; 2) facilitate and stimulate scientific discussion, networking and collaboration; 3) encourage professional development of newer scientists and scientists from underrepresented groups; and 4) transition the conference series to a business model that requires little or no support from NIH. The organizing committee, comprised of experienced leaders from key disciplines in this multidisciplinary field, will choose meeting topics, themes and speakers, which will evolve with the dynamic and burgeoning field, and will strategize about how to encourage attendance by scientists from a wide range of biomedical fields who could benefit from understanding how lipidomics research could be applied to their research. We will continue the open, collaborative and stimulating atmosphere of past LIPID MAPS Annual Meetings in order to maximize the ability of scientists at all levels, from diverse fields, and fro different institutions, companies and countries, to interact as productively as possible, resulting
in scientific advances and increased collaborative efforts. It is important to note that this is th only regular annual meeting in the world that focuses on lipidomics. Funds from this proposal will be used to provide travel funds for speakers, to subsidize student and postdoctoral attendees, and fund special administrative evaluation and website promotion (IT) support related to outreach.
描述(由申请人提供):本提案旨在通过在2014年、2015年和2016年举办一系列年度“脂质组学的影响”科学会议,继续和扩大非常成功的脂质地图年会,重点关注脂质组学及其生物医学应用。继基因组学和蛋白质组学的许多倡议之后,NIGMS赞助的LIPID MAPS是世界上第一个主要的脂质组学倡议。自2003年成立以来,该研究所的任务是积极主动地与整个研究界分享其数据、方法、工具和其他资源。其最成功的外联机制之一是其公开年度会议-2012年5月举行的第四次会议。自2002年“脂质组学”一词首次用于科学出版物和资助申请以来,该领域已经有了相当大的增长。2012年,NIH资助的项目总数超过130个,脂质组学出版物总数已超过700篇。LIPID MAPS计划将于2013年7月结束,无法延期,已经产生了数百种出版物。脂质组学的科学使用系统生物学方法和复杂的质谱仪来识别和量化细胞和组织中的脂质种类,并量化这些种类对扰动或疾病的反应。其最终目标是更好地了解脂质代谢在分子水平上的基本生物学过程,脂质在广泛的脂质疾病中发挥的积极作用,并促进更有效的药物干预和治疗的发展。该系列的总体目标是激励和促进脂质组学领域的进步,同时将脂质组学的应用扩展到细胞生物学,生物化学,药理学和生物医学的新领域。主要目标是:1)传播新的发现,方法和工具; 2)促进和刺激科学讨论,网络和合作; 3)鼓励新科学家和来自代表性不足群体的科学家的专业发展; 4)将会议系列转变为需要很少或不需要NIH支持的商业模式。组织委员会由来自这一多学科领域的关键学科的经验丰富的领导者组成,将选择会议主题,主题和发言人,这些主题将随着动态和新兴领域的发展而发展,并将制定战略,如何鼓励来自广泛生物医学领域的科学家参加,他们可以从了解脂质组学研究如何应用于他们的研究中受益。我们将继续保持过去LIPID MAPS年会的开放,合作和激励气氛,以最大限度地提高来自不同领域,不同机构,公司和国家的各级科学家的能力,尽可能富有成效地进行互动,
在科学进步和加强合作方面。值得注意的是,这是世界上唯一一次关注脂质组学的定期年会。该提案的资金将用于为演讲者提供差旅费,资助学生和博士后与会者,并资助与外联有关的特别行政评估和网站推广(IT)支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD A DENNIS其他文献
EDWARD A DENNIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD A DENNIS', 18)}}的其他基金
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
生物活性代谢物调节癌症免疫治疗中与免疫相关的不良事件
- 批准号:
10654674 - 财政年份:2021
- 资助金额:
$ 1.13万 - 项目类别:
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS
基于脂质组学的非酒精性脂肪性肝炎诊断
- 批准号:
9313262 - 财政年份:2015
- 资助金额:
$ 1.13万 - 项目类别:
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS
基于脂质组学的非酒精性脂肪性肝炎诊断
- 批准号:
8940970 - 财政年份:2015
- 资助金额:
$ 1.13万 - 项目类别:
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS
基于脂质组学的非酒精性脂肪性肝炎诊断
- 批准号:
9132243 - 财政年份:2015
- 资助金额:
$ 1.13万 - 项目类别:
VISUALIZING LOCALIZATION & TRANSLOCATION OF THREE TYPES OF PHOSPHOLIPASE A2
可视化本地化
- 批准号:
7358028 - 财政年份:2006
- 资助金额:
$ 1.13万 - 项目类别:














{{item.name}}会员




